Cancer BiologybioRxiv
Antibody Targeting of B7-H4 Enhances the Immune Response in Urothelial Carcinoma
J. R. Podojil, A. P. Glaser, D. Baker…·J. J. Meeks
This study identifies B7-H4 as a potential therapeutic target in bladder cancer, showing that anti-B7-H4 antibodies enhance immune responses and reduce tumor size in preclinical models.